Surviving a SARS-CoV-2 infection may be a reason to be more vigilant about general CV prevention measures moving forward.

The experts provide a how-to on dealing with sticky situations, such as no-flow and large thrombus, during PCI for STEMI.

The novel GLP-1 receptor agonists will likely reduce the need for CABG and improve surgical outcomes, several argue.

Whether to use ATP is not clear-cut and the choice should be made through shared decision-making, one expert says.

Cellular immunotherapies for cancer are associated with a low rate of serious adverse cardiac events in patients with ...

A study reinforces the importance of supporting the arm and placing the BP cuff at heart level, as guidelines recommend.

The incidental mammogram finding isn’t a reason to panic, but it might a reason to make sure other risk factors are under ...

Guideline recommendations for acute pulmonary embolism (PE) developed by prominent professional societies give a mixed bag of advice across the US and Europe, according to a paper published online ...

With a much longer half-life than other radiotracers, flurpiridaz F-18 will boost patient access to PET imaging, one expert ...

The randomized study lasted just 3 months, but researchers saw “multiple cardiometabolic benefits” beyond weight loss.

Two new analyses from HELIOS-B answer important questions, but some uncertainties remain, says Julie Rosenthal.

Indications that the GLP-1 drug has greater benefits in the most frail patients should be viewed cautiously, one expert says.